Ethanol Effects on Apparent Solubility of Poorly Soluble Drugs in Simulated Intestinal Fluid

Ethanol Effects on Apparent Solubility of Poorly Soluble Drugs in Simulated Intestinal Fluid

Publication: Mol Pharm
Software: ADMET Predictor®

Ethanol intake can lead to an unexpected and possibly problematic increase in the bioavailability of druglike compounds. In this work we investigated the effect of ethanol on the apparent solubility...

Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions

Novel physiologically based pharmacokinetic modeling of patupilone for human pharmacokinetic predictions

Publication: Cancer Chemother Pharmacol
Software: GastroPlus®

Patupilone (EPO906) is a novel potent microtubule stabilizer, which has been evaluated for cancer treatment. A novel physiologically based pharmacokinetics (PBPK) model was developed...

Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: a retrospective analysis

Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: a retrospective analysis

Publication: Urol Oncol

Objectives: Sarcomatoid metastatic renal cell carcinoma (mRCC) represents an aggressive subset of disease, and a definitive therapeutic strategy is lacking. We seek to define...

Development of a Robust Cytopathic Effect-Based High-Throughput Screening Assay To Identify Novel Inhibitors of Dengue Virus

Development of a Robust Cytopathic Effect-Based High-Throughput Screening Assay To Identify Novel Inhibitors of Dengue Virus

Publication: Antimicrob Agents Chemother

We have developed a robust cytopathic effect-based high-throughput screening assay to identify inhibitors of dengue virus (DENV) infection.

Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment

Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment

Publication: Rev Environ Contam Toxicol

In this review we have examined the status of parameters required by pyrethroid QSAR-PBPK/PD models for assessing health risks.